Clinical Trial Update: The Effect of a SGLT2 Inhibitor on Glucose Flux, Lipolysis and Exercise in Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effects of an SGLT2 inhibitor on glucose flux, lipolysis, and exercise in adults with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Leicester | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED